The effects of methanolic, chloroform, and ethylacetate extracts of the cucurbita pepo L. On the delay type hypersensitivity and antibody production

Research in Pharmaceutical Sciences

Volumn 7, Issue 4, 2012, Pages 217-224

  Jafarian, A ^a   Zolfaghari, B ^a   Parnianifard, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acquired immunity; Cucurbita pepo L.; Innate immunity; Pumpkin

Indexed keywords

ACETIC ACID ETHYL ESTER; BETAMETHASONE; CHLOROFORM; CUCURBITA PEPO EXTRACT; LEVAMISOLE; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FOOT EDEMA; HUMORAL IMMUNITY; IMMUNOMODULATION; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PAW EDEMA; SHEEP ERYTHROCYTE;

EID: 84873360626     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286:208-216.
2. Marcus DM, Grollman AP. Botanical medicines: The need for new regulations. N Engl J Med. 2002;347:2073-2076.
3. Robinson MR, Zhang X. The World Medicines Situation, 3rd Ed. Traditional medicine: Global situation, issues and challenges, WHO, Geneva, 2011.
4. Giampan JS, Rezende JAM, Silva RF. Reaction of cucurbits species to infection with Zucchini lethal chlorosis virus. Scientia Horticulturae. 2007;114:129-132.
5. Whitaker TW, Davis GN. Cucurbits. New York: Interscience Publ. Inc.1962.
6. Robinson RW, Decker-Walters DS. Cucurbits. New York: CAB International.1997.
7. Taylor MJ, Brant J. Trends in world cucurbit production, 1991 to 2001. In: Maynard DN (ed), Cucurbitaceae. Alexandria, VA: ASHS Press, 2002;373-379.
8. Popovic M. On growing squash and pumpkin (Cucurbita sp.) in Yugoslavia. Savremena Poljoprivreda. 1971;11:59-71.
9. Jia W, Gao W, Tang L. Antidiabetic herbal drugs officially approved in China. Phytother Res.2007;17:1127-1134.
10. Adolfo AC, Michael H. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J Ethnopharmacol. 2007;99:325-348.
11. Caili F, Huan S, Quanhong L. A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Hum Nutr. 2006;61:73-80.
12. Xia T, Wang Q. Hypoglycaemic role of Cucurbita ficifolia (Cucurbitaceae) fruit extract in streptozotocin-induced diabetic rats. J Sci Food Agric. 2007;87:1753-1757.
13. Kwon YI, Apostolidis E, Kim YC, Shetty K. Health benefits of traditional corn, beans, and pumpkin: in vitro studies for hyperglycemia and hypertension management. J Med Food. 2007;10:266-275.
14. Cheong NE, Choi YO, Kim WY, Bae IS, Cho MJ, Hwang I, Kim JW, Lee SY, Cheong NE et al. Purification and characterization of an antifungal PR-5 protein from pumpkin leaves. 1997;7:214-219.
15. Ito Y, Maeda S & Sugiyama T. Suppression of 7, 12- dimethylbenz [a]anthracene-induced chromosome aberrations in rat bone marrow cells by vegetable juices. Mutat Res. 1986;172:55-60.
16. Hongjian Z, Xunyi N, Giangong D. Experimental study of the effect of Sophora flavescens Ait and Cucrbita pepo L. on benign prostatic hyperplasia. Chin J Surg Intergrated Tradit West Med. 1999;72:42-50.
17. Liu T, Zhang M, Zhang H, Sun H, Yang X, Deng Y, Ji W. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer. Eur J Pharmacol. 2008;587:78-84.
18. Nakashima S., Matsuda H., Kurume A. Cucurbitacin E as a new inhibitor of cofilin phosphorilation in human leukemia u937 cells. Bioorg Med Chem Lett. 2010;20:2994-2997.
19. Escandell JM, Kaler P, Recio MC, Sasazuki T, Shirasawa S, Augenlicht L, et al. Activated kRas protects colon cancer cells from cucurbitacininduced apoptosis: The role of p53 and p21. Bioch Pharmacol. 2008;76:198-207.
20. Vassiliou AG, Neumann GM, Condron R, Polya GM. Purification and mass spectrometry-assisted sequencing of basic antifungal proteins from seeds of pumpkin (Cucurbita maxima). Plant Sci. 1998;134:141-162.
21. Diaz-Obrego D, Lloja-Lozano L, Carbajal-Zu. Preclinical studies of Cucurbita maxima (pumpkin seeds) a traditional intestinal antiparasitic in rural urban areas (article in Spanish). Rev Gastroenterol Peru. 2004;24:323-327.
22. Fahim AT, Abd-el Fattah AA, Agha AM, Gad MZ. Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant-arthritis in rats. Pharmacol Res. 1995;31:73-79.
23. Zuhair HA, Abd El-Fattah AA, El-Sayed MI. Pumpkin-seed oil modulates the effect of felodipine and captopril in spontaneously hypertensive rats. Pharmacol Res. 2002;41:555-563.
24. Wang P. Experimental study on pharmacological actions about analgesia, anti-inflammation of Cucurbita moschata Duch. Shizhen Med Mteria Med Res. 1999;19:567-569.
25. Caili F, Huan S, Quanhong L. A review on pharmacological activities and utilization technologies of pumpkin. Plant food Hum Nutr. 2006;61:73-80.
26. Xu GH. A study of the possible antitumour effect and immunom petence of pumpkin polysaccharide. J Wuhan Prof Med Coll. 2002;28:1-4.
27. Xia HC, Li F, Li Z, Zhang ZC. Purification and characterization of Moschatin, a novel type I ribosome-inactivating protein from the mature seeds of pumpkin (Cucurbita moschata), and preparation of its immunotoxin against human melanoma cells. Cell Res. 2003;13(5):369-374.
28. Hurtrel B, Maire MA, Hurtrel M, Lagrange PH. Different time course patterns of local expression of delayed-type hypersensitivity to sheep red blood cells in mice. Cell Immunol. 1992;142:252-263.
29. Belkaid Y, Valenzuela JG, Kamhawi S, Rowton E, Sacks DL, Ribeiro JM. Delayed-type hypersensitivity to Phlebotomous papatasi sand fly bite: an adaptive response induced by the fly. Proc Natl Acad Sci. 2000;97:6704-6709.
30. Barrington-Leigh J. The in vitro induction of delayed-type hypersensitivity to allo-antigens of the mouse. J Immunol Meth. 1984;69:149-163.
31. "Osterreichisches Arzneibuch". Wien: Editio Nona Osterreichisches-taatsdruckerei; 1960.
32. Momeni T. Herbal Extracts. Tehran: Reza Press; 2000.
33. Ough CS, Amerine MA. Methods for analysis musts and wines, John Wiley & Sons, New York. 1988;204-206.
34. Basseri HR, Safari N, Mousakazemi SH, Akbarzade K, Basseri HR et al. Comparison of midgut hemagglutination activity in three different geographical populations of Anopheles stephensi Iranian J Publ Health. 2004;33:60-67.
35. Koko WS, Mesaik MA, Yousaf S, Galal M, Choudhary MI. In vitro immunomodulating properties of selected Sudanese medicinal plants, J Ethnopharmacol. 2008;118:26-34.
36. Bafna AR, Mishra SH. Immunomodulatory activity of methanol extract of roots of Cissampelos pareira Linn. Ars Pharm. 2005;46:253-262.
37. Srisilam K, Sumalatha DV, Thilagam E, Veeresham C. Immunomodulators from higher plants, Indian J Nat Prod. 2000;20:3-15.
38. Pragathi D, Vijaya T, Anitha D, Mouli KC, Sai Gopal DVR. Botanical immunomodulators-potential therapeutic agents. J Global Pharma Technol. 2011;3:11-14.
39. Du B, Song Y, Hu X, Liao X, Ni Y, Li Q. Oligosaccharides prepared by acid hydrolysis of polysaccharides from pumpkin (Cucurbita moschata) pulp and their prebiotic activities. Int J Food Sci Technol. 2011;46:982-987.
40. Emily C. Barker, Tonibelle N. Gatbonton-Schwager, Yong Han, Jennifer E. Clay, John J. Letterio and Gregory P. Tochtrop bryonolic acid: A large-scale isolation and evaluation of heme oxygenase 1 expression in activated macrophages J Nat Prod. 2010;73:1064-1068.
41. Elliott AB, Chakravart EF. Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases. Women's Health 2010;6:431-442.
42. van Runnard Heimel PJ, Franx A, Schobben AFAM, Huisjes AJM, Derks JB, Bruinse HW. Corticosteroids, Pregnancy, and HELLP Syndrome: A Review. Obstetrical Gynecol Survey. 2005;60:57- 70.
43. Fabrizi I F, Dixit V, Messa I P, Martin P. Metaanalysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients. Alimentary Pharmacol Ther. 2010;32: 756-762.
44. Tannin-Spitz T, Bergman M, Grossman S. Cucurbitacin glucosides: Antioxidant and freeradical scavenging activities. Biochem Biophysic Res. 2007;364:181-186.
45. Chan TK, Meng FY, Li Q Ho CY, Lam TS, To Y, Lee WH, et al. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Letters.2010;294:118- 124.
46. Chan TK., Li K., Lam Liu S, Chu KH, Toh M, Xieand WD. Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett. 2010;289:46-52.
47. Tarhan L, Kayali HA, Urek RO. In vitro antioxidant properties of Cucurbita pepo L. male and female flowers extracts. Plant food Hum Nutr. 2007;62:49- 51.
48. Sicilia T, Niemeyer HB, Honig DM, Metzler M. Identification and stereochemical characterization of lignans in flaxseed and pumpkin seeds. J Agric Food Chem. 2003;26:1181-1188.
49. Rodriguez JB, Gros EG, Bertoni MH, Cattaneo P. The sterols of Cucurbita moschata ("calabacita") seed oil. Lipids. 1996;31:1205-1208.
50. Murkovic M, Hillebrand A, Winkler J, Leitner E, Pfannhauser W. Variability of fatty acid content in pumpkin seeds (Cucurbita pepo L.). Z. Lebensm Unters Forsch. 1996;203:216-219.
51. Matus Z, Molnar P, Szabo LG. Main carotenoids in pressed seeds (Cucurbitae semen) of oil pumpkin (Cucurbita pepo convar. pepo var. styriaca). Acta Pharm Hung. 1993;63:247-256.